174 related articles for article (PubMed ID: 15021970)
1. Competition between IL-1, IL-1ra and TGF-beta 1 modulates the response of the ELA4.NOB-1/CTLL bioassay: implications for clinical investigations.
Ashwood P; Harvey R; Verjee T; Wolstencroft R; Thompson RP; Powell JJ
Inflamm Res; 2004 Feb; 53(2):60-5. PubMed ID: 15021970
[TBL] [Abstract][Full Text] [Related]
2. Functional interactions between mucosal IL-1, IL-ra and TGF-beta 1 in ulcerative colitis.
Ashwood P; Harvey R; Verjee T; Wolstencroft R; Thompson RP; Powell JJ
Inflamm Res; 2004 Feb; 53(2):53-9. PubMed ID: 15021969
[TBL] [Abstract][Full Text] [Related]
3. [Effects of IL-1 receptor antagonist on the level of cytokine in the rat corneal grafts and aqueous humor after corneal transplantation].
Zhang WH; Zhai CB; Pan ZQ; Wu YY
Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):587-91. PubMed ID: 14766071
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells.
Wirjatijasa F; Dehghani F; Blaheta RA; Korf HW; Hailer NP
J Neurosci Res; 2002 Jun; 68(5):579-87. PubMed ID: 12111847
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta mediates IL-1-dependent induction of IL-1 receptor antagonist.
Wahl SM; Costa GL; Corcoran M; Wahl LM; Berger AE
J Immunol; 1993 Apr; 150(8 Pt 1):3553-60. PubMed ID: 8468489
[TBL] [Abstract][Full Text] [Related]
6. A corneal epithelial inhibitor of stromal cell collagenase synthesis identified as TGF-beta 2.
Strissel KJ; Rinehart WB; Fini ME
Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):151-62. PubMed ID: 7822142
[TBL] [Abstract][Full Text] [Related]
7. Role of growth factors on extracellular matrix production by chick embryo fibroblasts in vitro. Antagonist effect of TGF-beta through the control of IL-1 and IL-1Ra secretion.
Bodo M; Carinci P; Baroni T; Bellucci C; Giammarioli M; Pezzetti F; Becchetti E
Cytokine; 1998 May; 10(5):353-60. PubMed ID: 9619373
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
[TBL] [Abstract][Full Text] [Related]
9. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro.
Danforth DN; Sgagias MK
Cancer Res; 1993 Apr; 53(7):1538-45. PubMed ID: 8453620
[TBL] [Abstract][Full Text] [Related]
11. Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells.
Muzio M; Sironi M; Polentarutti N; Mantovani A; Colotta F
Eur J Immunol; 1994 Dec; 24(12):3194-8. PubMed ID: 7805748
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1, IL-1beta, and Th2 cytokines stimulate vascular endothelial growth factor production from conjunctival fibroblasts.
Asano-Kato N; Fukagawa K; Okada N; Kawakita T; Takano Y; Dogru M; Tsubota K; Fujishima H
Exp Eye Res; 2005 Apr; 80(4):555-60. PubMed ID: 15781283
[TBL] [Abstract][Full Text] [Related]
13. Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease.
Holmlund A; Hänström L; Lerner UH
J Clin Periodontol; 2004 Jun; 31(6):475-82. PubMed ID: 15142219
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factors beta slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line.
Stoeck M; Miescher S; MacDonald HR; Von Fliedner V
J Cell Physiol; 1989 Oct; 141(1):65-73. PubMed ID: 2789227
[TBL] [Abstract][Full Text] [Related]
15. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
Braundmeier AG; Nowak RA
Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
[TBL] [Abstract][Full Text] [Related]
16. Effect of cytokines on prostaglandin E2 and prostacyclin production in primary cultures of human myometrial cells.
Todd HM; Dundoo VL; Gerber WR; Cwiak CA; Baldassare JJ; Hertelendy F
J Matern Fetal Med; 1996; 5(4):161-7. PubMed ID: 8796788
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor beta (TGF-beta1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway.
Kwong KY; Literat A; Zhu NL; Huang HH; Li C; Jones CA; Minoo P
Life Sci; 2004 Apr; 74(24):2941-57. PubMed ID: 15051419
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
19. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta.
Turner M; Chantry D; Katsikis P; Berger A; Brennan FM; Feldmann M
Eur J Immunol; 1991 Jul; 21(7):1635-9. PubMed ID: 1829411
[TBL] [Abstract][Full Text] [Related]
20. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
François M; Richette P; Tsagris L; Fitting C; Lemay C; Benallaoua M; Tahiri K; Corvol MT
Arthritis Rheum; 2006 Apr; 54(4):1233-45. PubMed ID: 16572457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
